Workflow
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
BMRNBioMarin Pharmaceutical(BMRN) Zacks Investment Research·2024-02-22 23:16

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of 0.49pershare,beatingtheZacksConsensusEstimateof0.49 per share, beating the Zacks Consensus Estimate of 0.44 per share. This compares to earnings of 0.36pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof11.360.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 11.36%. A quarter ago, it was expected that this rare disease biopharmaceutical would post earnings of 0.46 per share when it actually produced earnings of $0.46, delivering no surprise.Over the last four ...